Impact BioMedical IBO CEO lays out novel drug pipeline priorities to drive longterm global market expansion ATRC AtriCure delivers big Q4 2025 earnings upside shares rise 379 percent on upbeat investor reaction CFTC Prediction Market Oversight Insider Trading Crackdown and Regulatory Dispute Update